Table 1.
Adverse Effects after Vaccination with Inactivated Influenza Virus Vaccine With or Without QS21 Adjuvant
No. Subjects with Indicated Severity (0-3) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Aqueous Vaccine | QS21 Vaccine | ||||||||
Evaluation Time | Adverse Effect | 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 |
Day 0 (Observed) | Local Pain:1 | ||||||||
Immediate | 14 | 1 | 0 | 0 | 13 | 2 | 0 | 0 | |
At 30 min | 13 | 2 | 0 | 0 | 5 | 9 | 1 | 0 | |
Day 1 (Observed) | Local: | ||||||||
Pain1 | 7 | 8 | 0 | 0 | 2 | 9 | 4 | 0 | |
Redness2 | 15 | 0 | 0 | 0 | 14 | 1 | 0 | 0 | |
Swelling/induration2 | 15 | 0 | 0 | 0 | 14 | 1 | 0 | 0 | |
Systemic:3 | |||||||||
Fever | 15 | 0 | 0 | 0 | 14 | 15 | 0 | 0 | |
Feverish | 15 | 0 | 0 | 0 | 13 | 2 | 0 | 0 | |
Headache | 14 | 1 | 0 | 0 | 12 | 3 | 0 | 0 | |
Fatigue | 14 | 1 | 0 | 0 | 10 | 5 | 0 | 0 | |
Myalgias | 15 | 0 | 0 | 0 | 10 | 5 | 0 | 0 | |
Days 1-74 (Diary) | Local: | ||||||||
Pain1 | 7 | 4 | 4 | 0 | 1 | 3 | 11 | 0 | |
Redness2 | 15 | 0 | 0 | 0 | 13 | 2 | 0 | 0 | |
Swelling2 | 15 | 0 | 0 | 0 | 13 | 2 | 0 | 0 | |
Systemic:3 | |||||||||
Fever | 15 | 0 | 0 | 0 | 14 | 1 | 0 | 0 | |
Headache | 10 | 4 | 1 | 0 | 9 | 5 | 1 | 0 | |
Fatigue | 11 | 4 | 0 | 0 | 8 | 6 | 1 | 0 | |
Myalgias | 15 | 0 | 0 | 0 | 6 | 6 | 3 | 0 | |
Nausea/vomiting | 12 | 2 | 1 | 0 | 13 | 2 | 0 | 0 |
0 = none, 1 = tender to touch, 2 = hurts to move, 3 = unable to move
0 = none, 1 = 0.5 – 5 cm, 2 = 5 – 10 cm, 3 = >10 cm
0 = none, 1 = slight/mild, 2 = interferes with activity, 3 = incapacitating
Highest severity for day 1-7 interval
Temp = 100.6°F